Senior adviser, DBT Dr Renu Sahay, secretary DBT Dr K Vijay Raghavan & India's S&T minister Dr Harsh Vardhan at the launch ceremony of National Biotechnology Development Strategy 2015-20 |
To keep pace with the revolutionary global
advances in biotechnology, which has given novel agricultural, health, energy
and environmental products, India has formulated its own ambitious strategy to
emerge as a major player in this field.
The National Biotechnology Development Strategy: 2015-20 has
set a target of taking the current biotechnology industry size from $ 7 billion
to $ 100 billion by 2025. The 36-page document prepared after discussing with
various stakeholders over two years was formally released today by union
minister of S&T and Earth Sciences, Dr Harsh Vardhan.
The Strategy has for the first time opened the door for
global public-private partnership which will usher global giants to establish
their R&D Centres and manufacturing units in India with the help of government.
Will this not hamper the growth of indigenous biotech companies? Dr Renu Sahay,
the senior advisor in the Department of Biotechnology says, ‘No, it would, on the
contrary, expose indigenous companies to global standards, practices and
technologies. Ultimately they would benefit from all this.’
The general feeling among policy makers in India is that biotechnology
holds similar promise of sparkling growth in India which information technology
(IT) has been able to demonstrate in the past two decades. But India’s remarkable
success in IT did not require any global public-private partnership, then why this
is needed in the field of biotechnology? Dr K Vijay Raghavan, secretary
Department of Biotechnology says, ‘India’s success in the IT sector is in
services, which did not require this, but biotechnology is a much more complex thing which needs a lot of high tech research,
therefore, partnering with global players would help India.’
The Strategy cannot succeed without developing quality human resource in
sufficient number that is not only highly skilled in bio-chemistry and bio-sciences but also innovative and possessing entrepreneurship. To take care of this issue, several initiatives
have been formulated including launching of dual degree MSc-MBA programmes in
agribusiness, pharma business and bio enterprise management.
To spur research, several plans have been enumerated in the Strategy including giving due focus on translational research to convert basic research into technology to manufacture useful products. The plan is to establish Technology
Development & Translational Cells in fifty research intensive universities of the country.
This apart, 150 Technology Transfer Organisations would be set up across the
country in research institutes and universities. All this will help in carrying
forward four major biotechnology missions in healthcare, food and nutrition,
clean energy and education.
The new Strategy has been formulated on the foundation laid down
by an earlier strategy scripted for 2007-12 that was adopted by the UPA government in 2007
which helped the country establishing a robust infrastructure which led to numerous
successes. Owing to this, two thirds of the world’s children today get at least
one of the vaccines that is produced in India. It could evolve necessary
guidelines for transgenic plants, recombinant vaccines & drugs, stem cell
therapy etc.
India could have done much better, but for the unpredictable
changes in the way science and technology is done globally. Scientists in Indian
labs have been working with the low-end equipments and most of the components had
to be imported. It is being felt they can be easily produced in India at a
fraction of the cost, says Dr K Vijay Raghavan. The new strategy has taken care of such issues perhaps because it has been formulated in
consultation with the Niti Ayog which wants to promote innovation and entrepreneurship
in all fields.
There have been terrific developments in biotechnology in
recent years with the revolutionary new ways of gene editing posing new legal,
scientific and regulatory challenges. This aspect has been taken care of in the
new strategy.